Vitamin B12 / GSH Cancer Research Results

VitB12, Vitamin B12: Click to Expand ⟱
Features:

Vitamin B12 = cobalamin (water-soluble vitamin; forms: methylcobalamin, adenosylcobalamin, cyanocobalamin, hydroxocobalamin). Sources: animal-derived foods; requires intrinsic factor–mediated absorption; transport via transcobalamin (TCII). Primary mechanisms (ranked):
1) Methionine synthase cofactor → homocysteine → methionine → SAM → DNA/RNA/histone methylation (one-carbon metabolism integration).
2) Methylmalonyl-CoA mutase cofactor → odd-chain FA / branched-chain AA metabolism; mitochondrial anaplerosis support.
3) Genome stability support (via nucleotide synthesis + methylation balance).
Bioavailability/PK relevance: Active absorption saturable (~1–2 µg/meal via IF); passive diffusion at high oral doses (~1%); serum levels tightly regulated; intracellular utilization depends on TCII uptake and lysosomal processing.
In-vitro vs oral exposure: Most cancer cell studies use supraphysiologic cobalamin or manipulate one-carbon flux; effects typically reflect methylation / nucleotide synthesis dependency rather than direct cytotoxicity.
Clinical evidence status: Essential nutrient; deficiency correction clearly beneficial; no established anticancer efficacy; epidemiology mixed (very high serum B12 sometimes correlates with cancer presence—likely reverse causality/biomarker phenomenon rather than causation).

Helps make red blood cells, metabolize food and prevent nerve damage.

Vitamin B12 (Cobalamin) — Cancer vs Normal Pathway Effects

Rank Pathway / Axis Cancer Cells (↑ / ↓ / ↔) Normal Cells (↑ / ↓ / ↔) TSF Primary Effect Notes / Interpretation
1 One-carbon metabolism (Methionine synthase → SAM) ↑ methylation capacity; ↑ nucleotide synthesis (proliferation support) ↑ genome stability; ↑ normal DNA synthesis R→G Methyl donor cycling Supports SAM production; in rapidly dividing tumors may facilitate growth if not limiting.
2 DNA methylation / Epigenetics ↔ / ↑ (context-dependent; can restore normal methylation if deficient) ↑ methylation homeostasis G Epigenetic stability Deficiency → hypomethylation/genomic instability; supplementation restores baseline rather than inducing supraphysiologic hypermethylation in most settings.
3 Nucleotide synthesis (via folate cycle coupling) ↑ proliferation support (if B12 limiting) ↑ normal hematopoiesis R→G DNA replication capacity Mechanistically linked to folate; deficiency leads to megaloblastic anemia.
4 Mitochondrial metabolism (Methylmalonyl-CoA mutase) ↔ (supports baseline metabolism) ↑ mitochondrial function R Anaplerotic support Prevents methylmalonic acid accumulation; preserves mitochondrial efficiency.
5 ROS ↔ (indirect) ↓ oxidative stress (deficiency correction) R Redox balance (secondary) Effects mediated through improved mitochondrial and methylation balance.
6 NRF2 ↔ (no direct axis) ↔ G Adaptive response (indirect) No primary NRF2-targeting activity established.
7 Ca2+ ↔ ↔ P Not a core pathway No meaningful Ca²⁺ modulation axis.
8 HIF-1α / Warburg ↔ (indirect via proliferation capacity) ↔ G Metabolic permissiveness No direct hypoxia pathway targeting; effects are permissive rather than suppressive.
9 Ferroptosis ↔ ↔ R Not established No defined ferroptotic mechanism.
10 Clinical Translation Constraint Essential nutrient; correction of deficiency critical. No validated anticancer benefit; very high serum B12 often reflects disease state rather than supplementation causality. — Evidence Interpret epidemiologic associations cautiously (reverse causation common).

TSF legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr
GSH, Glutathione: Click to Expand ⟱
Source:
Type:
Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress.
Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system.
cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment.
While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied.
Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy.
Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death.
Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion.
Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS).

"...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..."
"Cancer cells have a high level of GSH compared to normal cells."
"...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy."

The loss of GSH is broadly known to be directly related to the apoptosis progression.
Scientific Papers found: Click to Expand⟱
4037- VitB12,  FA,    Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
- Review, AD, NA
*antiOx↑, *ROS↓, *GSH↑, *Inflam↓, *IL6↓, *TNF-α↓, *other↑, *other↑, *other↑, *Aβ↓, *memory↑, *p‑tau↓, *APP↓, *BACE↓, *ATP↑, *neuroP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,   GSH↑, 1,   ROS↓, 1,  

Mitochondria & Bioenergetics ⓘ

ATP↑, 1,  

Transcription & Epigenetics ⓘ

other↑, 3,  

Migration ⓘ

APP↓, 1,  

Immune & Inflammatory Signaling ⓘ

IL6↓, 1,   Inflam↓, 1,   TNF-α↓, 1,  

Synaptic & Neurotransmission ⓘ

p‑tau↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,   BACE↓, 1,  

Clinical Biomarkers ⓘ

IL6↓, 1,  

Functional Outcomes ⓘ

memory↑, 1,   neuroP↑, 1,  
Total Targets: 15

Scientific Paper Hit Count for: GSH, Glutathione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:165  Target#:137  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page